Ventum Cap Mkts Weighs in on Ascend Wellness Q4 Earnings

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Ventum Cap Mkts issued their Q4 2024 EPS estimates for Ascend Wellness in a research report issued on Tuesday, November 12th. Ventum Cap Mkts analyst A. Semple anticipates that the company will earn ($0.07) per share for the quarter. The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.32) per share. Ventum Cap Mkts also issued estimates for Ascend Wellness’ FY2025 earnings at ($0.26) EPS and FY2026 earnings at ($0.18) EPS.

Ascend Wellness (OTC:AAWH) last issued its earnings results on Tuesday, November 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). Ascend Wellness had a negative return on equity of 72.18% and a negative net margin of 15.47%. The firm had revenue of $141.65 million during the quarter, compared to analysts’ expectations of $144.13 million.

Ascend Wellness Price Performance

Shares of OTC:AAWH opened at $0.47 on Friday. The company has a current ratio of 1.47, a quick ratio of 1.29 and a debt-to-equity ratio of 2.61. Ascend Wellness has a twelve month low of $0.42 and a twelve month high of $1.82. The company’s 50 day moving average is $0.82 and its 200 day moving average is $0.95. The company has a market cap of $99.66 million, a PE ratio of -1.13 and a beta of 1.69.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.